Clinical Trial Update: ROSA Total Knee Post Market Study EMEA [NA]

View source ↗

Summary

Zimmer Biomet's ROSA Total Knee post-market study in the EMEA region has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Condyle
• Knee Deformities
• Osteoarthritis Knee
• Rheumatoid Arthritis

Drugs mentioned

• ROSA Total Knee System

Snippet

Sponsor: Zimmer Biomet | Conditions: Knee Pain, Chronic Osteoarthritis | NA | Status: COMPLETED | Results posted: 2026-01-21